TICOP Mobile App and E-platform: Providing Information and Support for Parents Caring for Their Child Cancer Survivor
NCT03945032 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-12-11
Summary
This study aims to develop a mobile App (named "TICOP") for parents of a childhood cancer survivor and an E-Platform for health professionals which work in pediatric oncology area.
The core objective is to evaluate the effects of these two digital tools (mobile app and platform) in the detection and prevention among parents of a childhood cancer survivor.
Conditions
- Mobile Application
Interventions
- OTHER
-
TICOP
Parent moves the cursor by analogy on their mobile phone (as a visual anagogic scale) four times per year (baseline; month 4; month 8 and month 12).
Sponsors & Collaborators
-
Vander Haegen Marie
lead OTHER
Principal Investigators
-
Marie Vander Haegen, Dr. · University of Liege
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-15
- Primary Completion
- 2022-11-02
- Completion
- 2025-05-15
Countries
- Belgium
Study Locations
More Related Trials
-
Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00002537 ·Status: COMPLETED ·Phase: PHASE1
-
Statin Therapy in Young Adult Survivors of Childhood Cancer
NCT01733953 ·Status: COMPLETED ·Phase: PHASE2
-
Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma
NCT00002625 ·Status: COMPLETED ·Phase: PHASE1
-
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
NCT00972205 ·Status: COMPLETED ·Phase: NA
-
A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport
NCT05150028 ·Status: COMPLETED ·Phase: NA
-
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
NCT03143894 ·Status: TERMINATED ·Phase: NA
-
Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
NCT00002587 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors
NCT02031055 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome
NCT01104415 ·Status: COMPLETED ·Phase: PHASE2
-
Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies
NCT00083525 ·Status: COMPLETED ·Phase: PHASE1
-
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
NCT01497925 ·Status: COMPLETED ·Phase: PHASE1
-
Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
NCT00193570 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT03553537 ·Status: UNKNOWN ·Phase: PHASE3
-
The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC
NCT04170959 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
NCT01998529 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
NCT01328054 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Methylphenidate on Cancer-related Cognitive Impairment
NCT02970500 ·Status: TERMINATED ·Phase: PHASE2
-
Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
NCT00016354 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT02828462 ·Status: UNKNOWN
-
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
NCT01382706 ·Status: TERMINATED ·Phase: PHASE2
-
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
NCT00061919 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
NCT01053104 ·Status: COMPLETED
-
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
NCT00709215 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
NCT00077064 ·Status: TERMINATED ·Phase: PHASE2
-
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors
NCT00628732 ·Status: COMPLETED ·Phase: PHASE2